CP137329422 | FDA panel debates lower-dose Moderna COVID booster

CP137449971 | FDA panel endorses booster for single-shot vaccine

CP137437671 | FDA panel debates booster for single-dose vaccine

CP138908121 | FDA panel backs Pfizer's COVID-19 vaccine for kids

CP138236322 | CDC panel backs booster expansion despite concerns

CP153540072 | FDA: 50 and up can get 2nd Pfizer, Moderna booster

CP143124202 | FDA panel narrowly backs COVID-19 pill from Merck

CP125287571 | Vaccine panel says Pfizer, Moderna are 'preferred' as second doses

CP143421871 | NACI recommends boosters for people over 50

CP25007832 | FDA clears updated COVID boosters for younger kids

FDA panel backs lower-dose Moderna COVID booster

A U.S. health advisory panel endorsed booster shots for Moderna’s COVID-19 vaccine, voting to recommend a lower-dose shot for seniors and other high-risk groups. But it stressed there's no evidence it's time to open booster doses to everybody. (Oct. 14)

Source name:

Unique identifier: CP137360871

Legacy Identifier: 5555ad5807594997937aec417dd724e3

Type: Video

Duration: 1m20s

Dimensions: 1920px × 1080px 98.41 MB

Usage rights: Digital platform use only. Broadcast rights and editing of content prohibited.

Create Date: 10/14/2021 5:54:25 PM

Display aspect ratio: 16:9